MATINAS BIOPHARMA HOLDINGS, INC. Notes Assumed
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Notes Assumed of $399.68 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NotesAssumed1 · last filed 2020-03-09
- MATINAS BIOPHARMA HOLDINGS, INC. notes assumed for the quarter ending 2018-12-31 was $0.00.
- MATINAS BIOPHARMA HOLDINGS, INC. notes assumed for the quarter ending 2017-12-31 was $0.00.
- MATINAS BIOPHARMA HOLDINGS, INC. notes assumed for fiscal 2018 was $399.68K, a 4.35% increase from fiscal 2017.
- MATINAS BIOPHARMA HOLDINGS, INC. notes assumed for fiscal 2017 was $383.03K.
| Period end | Notes Assumed 3 month | Notes Assumed 9 month | Notes Assumed 12 month |
|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $399.68K 10-K · filed 2020-03-09 | |
| 2018-09-30 | $399.68K 10-Q · filed 2019-11-13 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $383.03K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $383.03K 10-Q · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |